Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Farm Products

CHS Inc., an integrated agricultural company, provides grains, foods, and energy resources to businesses and consumers in North America, South America, Europe, the Middle East, Africa, and the Asia Pacific. The company operates through three segments: Energy, Ag, and Nitrogen Production. It is involved in the operation of petroleum refineries and pipelines; supply, marketing, and distribution of refined fuels, including gasoline, diesel fuel, and other energy products; blending, sale, and distribution of lubricants; and the supply of propane and other natural gas liquids. The company also processes and sells crude oil into refined petroleum products under the Cenex brand name to member cooperatives and other independent retailers through a network of approximately 1,500 sites; and provides transportation services. In addition, it markets grains and oilseeds; and offers seeds, crop nutrients, crop protection products, animal feed, animal health products, refined and renewable fuels, and propane, as well as refined oils, meal, soy flour, and processed sunflower products. Further, the company produces and sells nitrogen-based products, including methanol, UAN and urea, and related products; and offers cooperatives with various loans that meet commercial agriculture needs and loans to individual producers, as well as consulting and commodity risk management services...
Website: chsinc.com



Growth: Bad revenue growth rate -3.3%, there is slowdown compared to average historical growth rates -2.7%. The revenue growth dynamics is unstable Site traffic for the last 3 months showed a change of +16.0%

Profitability: LTM EBITDA margin is positive, +3.5%. On average the margin is decreasing unsteadily. Gross margin is low, +4.5%.

Cash Flow Generation: Dividend yield for the last twelve months 7.2%. Free cash flow yield -179.3% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 3.4% higher than minimum and 16.5% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 1.5x by EV / Sales multiple , the company can be >100% undervalued

Key Financials (Download financials)

Ticker: CHSCP
Share price, USD:  (0.0%)27.78
year average price 28.09  


year start price 28.35 2025-02-14

min close price 26.87 2025-04-16

max close price 30.40 2025-09-15

current price 27.78 2026-02-13
Common stocks: 12 290 000

Dividend Yield:  7.2%
FCF Yield LTM: -179.3%
EV / LTM EBITDA: 1.7x
EV / EBITDA annualized: 3.5x
Last revenue growth (y/y):  -3.3%
Last growth of EBITDA (y/y):  -56.8%
Historical revenue growth:  -2.7%
Historical growth of EBITDA:  +21.5%
EV / Sales: 0.1x
Margin (EBITDA LTM / Revenue): 3.5%
Fundamental value created in LTM:
Market Cap ($m): 341
Net Debt ($m): 2 041
EV (Enterprise Value): 2 382
Price to Book: 0.0x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2024-05-23globenewswire.com

Coherus Presents Preliminary Results from Phase I Dose Escalation Study of its Anti-chemokine receptor 8 (CCR8) Antibody, CHS-114, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q4 2025 q3 2025 q2 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q3
date 2025-11-30 2025-08-31 2025-05-31 2024-08-31 2024-05-31 2024-02-29 2023-11-30 2023-08-31 2023-05-31 2023-02-28 2022-11-30 2022-08-31 2021-08-31
symbol CHSCP CHSCP CHSCP CHSCP CHSCP CHSCP CHSCP CHSCP CHSCP CHSCP CHSCP CHSCP CHSCP
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 823 277 823 277 823 277 823 277 823 277 823 277 823 277 823 277 823 277 823 277 823 277 823 277 823 277
fillingDate 2026-01-07 2025-07-09 2024-07-10 2024-04-03 2024-01-10 2023-07-13 2023-04-05 2023-01-11
acceptedDate 2026-01-07 11:00:59 2025-11-05 11:32:24 2025-07-09 11:50:59 2024-11-06 12:00:49 2024-07-10 11:30:51 2024-04-03 11:01:00 2024-01-10 12:45:33 2023-11-08 16:06:08 2023-07-13 11:01:06 2023-04-05 10:58:21 2023-01-11 13:00:49 2022-11-02 11:01:43 2021-11-04 08:01:15
calendarYear 2026 2025 2024 2024 2024 2023 2023 2023
period Q1 FY Q3 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY FY
revenue 8 864M 35 463M 9 766M 39 261M 9 609M 9 087M 11 391M 45 590M 12 026M 11 307M 12 766M 47 792M 38 448M
costOfRevenue 8 475M 34 326M 9 437M 37 510M 9 141M 8 749M 10 741M 43 214M 11 352M 10 923M 11 887M 45 099M 36 572M
grossProfit 389M 1 137M 330M 1 751M 468M 339M 649M 2 376M 674M 384M 879M 2 692M 1 876M
grossProfitRatio 0.044 0.034 0.049 0.037 0.057 0.056 0.034 0.069
researchAndDevelopmentExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0
generalAndAdministrativeExpenses 0 0 0 0 0 0 0 0 0 0 0 0 746M
sellingAndMarketingExpenses 0 0 0 0 0 0 0 0 0 0 0 0 1M
sellingGeneralAndAdministrativeExpenses 268M 1 046M 259M 1 155M 315M 297M 253M 1 033M 273M 242M 235M 998M 747M
otherExpenses 0 0 0 12M 0 0 0 0 0 0 235M 0 0
operatingExpenses 268M 1 046M 259M 1 167M 135M 297M 253M 1 033M 273M 242M 235M 998M 747M
costAndExpenses 8 743M 35 372M 9 695M 38 677M 9 276M 9 046M 10 994M 43 839M 11 625M 11 165M 12 121M 46 098M 37 318M
interestIncome 0 0 0 0 0 0 0 0 0 0 0 114M 105M
interestExpense 37M 146M 44M 104M 23M 25M 35M 137M 37M 36M 33M 120M 113M
depreciationAndAmortization 171M 651M 159M 482M 143M 140M 138M 465M -194M -207M 206M 462M 462M
ebitda 480M 1 412M 462M 1 684M 477M 182M 535M 2 610M 401M 142M 850M 2 386M 1 082M
ebitdaratio 0.054 0.047 0.031 0.02 0.047 0.033 0.013 0.067
operatingIncome 125M 91M 71M 584M 153M 41M 397M 1 751M 595M 349M 644M 1 694M 1 130M
operatingIncomeRatio 0.014 0.007 0.016 0.005 0.035 0.049 0.031 0.05
totalOtherIncomeExpensesNet 148M 524M 188M 513M 157M 144M 120M 257M -37M -36M 173M 116M -614M
incomeBeforeTax 272M 615M 259M 1 098M 310M 186M 517M 2 008M 558M 313M 817M 1 810M 515M
incomeBeforeTaxRatio 0.031 0.027 0.032 0.02 0.045 0.046 0.028 0.064
incomeTaxExpense 12M 17M 27M -5M 13M 15M -7M 108M 11M 21M 35M 132M -38M
netIncome 260M 598M 232M 1 102M 255M 170M 523M 1 900M 547M 292M 783M 1 679M 554M
netIncomeRatio 0.029 0.024 0.027 0.019 0.046 0.046 0.026 0.061
eps 0 0 0 0 0 0 0 0 0 23.76 63.7 0 0
epsdiluted 0 0 0 0 0 0 23.76 63.7
weightedAverageShsOut 0 0 0 0 0 0 0 0 0 12M 12M 0 0
weightedAverageShsOutDil 0 0 0 0 0 0 0 0 0 12M 12M 0 0
link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link
filingDate 2025-11-05 2024-11-06 2023-11-08 2022-11-02 2021-11-04
fiscalYear 2025 2024 2023 2022 2021
netInterestIncome -146M -104M -137M -6M -8M
ebit 761M 1 202M 2 145M 1 924M 620M
nonOperatingIncomeExcludingInterest -670M -617M -395M -230M 510M
netIncomeFromContinuingOperations 598M 1 103M 1 900M 1 678M 554M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 -340 000 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome 598M 1 102M 1 732M 1 679M 554M
epsDiluted 0 0 0 0 0

Balance Sheet Statement

Property 2025 q4 2025 q3 2025 q2 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q3
date 2025-11-30 2025-08-31 2025-05-31 2024-08-31 2024-05-31 2024-02-29 2023-11-30 2023-08-31 2023-05-31 2023-02-28 2022-11-30 2022-08-31 2021-08-31
symbol CHSCP CHSCP CHSCP CHSCP CHSCP CHSCP CHSCP CHSCP CHSCP CHSCP CHSCP CHSCP CHSCP
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 823 277 823 277 823 277 823 277 823 277 823 277 823 277 823 277 823 277 823 277 823 277 823 277 823 277
fillingDate 2026-01-07 2025-07-09 2024-07-10 2024-04-03 2024-01-10 2023-07-13 2023-04-05 2023-01-11
acceptedDate 2026-01-07 11:00:59 2025-11-05 11:32:24 2025-07-09 11:50:59 2024-11-06 12:00:49 2024-07-10 11:30:51 2024-04-03 11:01:00 2024-01-10 12:45:33 2023-11-08 16:06:08 2023-07-13 11:01:06 2023-04-05 10:58:21 2023-01-11 13:00:49 2022-11-02 11:01:43 2021-11-04 08:01:15
calendarYear 2026 2025 2024 2024 2024 2023 2023 2023
period Q1 FY Q3 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY FY
cashAndCashEquivalents 458M 399M 404M 795M 310M 709M 1 419M 1 845M 997M 462M 636M 903M 542M
shortTermInvestments 0 0 0 501M 0 0 0 0 0 0 0 0 0
cashAndShortTermInvestments 458M 399M 404M 1 296M 310M 709M 1 419M 1 845M 997M 462M 636M 903M 542M
netReceivables 3 989M 3 687M 4 198M 3 550M 2 614M 3 370M 3 773M 3 106M 3 839M 3 611M 4 277M 3 548M 2 861M
inventory 4 328M 3 375M 3 681M 3 201M 3 305M 4 585M 4 698M 3 351M 3 281M 4 858M 5 070M 3 852M 3 529M
otherCurrentAssets 1 127M 420M 644M 460M 1 158M 659M 698M 677M 1 269M 1 690M 1 482M 1 074M 1 066M
totalCurrentAssets 9 900M 8 086M 8 927M 8 709M 8 460M 9 323M 10 587M 9 129M 9 386M 10 622M 11 465M 9 378M 7 999M
propertyPlantEquipmentNet 5 464M 5 740M 5 455M 5 396M 5 033M 4 962M 4 877M 5 124M 4 757M 4 735M 4 729M 4 988M 5 063M
goodwill 0 239M 0 180M 0 0 0 180M 0 0 0 180M 172M
intangibleAssets 0 94M 0 42M 0 0 0 47M 0 0 0 53M 58M
goodwillAndIntangibleAssets 0 334M 0 222M 0 0 0 227M 0 0 0 233M 230M
longTermInvestments 4 099M 3 994M 3 981M 3 878M 3 894M 3 900M 3 929M 3 907M 3 906M 3 791M 3 891M 3 783M 3 669M
taxAssets 0 0 0 0 0 0 0 -180M 0 0 0 -180M -172M
otherNonCurrentAssets 1 280M 710M 1 324M 510M 1 071M 980M 1 040M 751M 1 145M 1 023M 989M 623M 786M
totalNonCurrentAssets 10 843M 10 777M 10 760M 10 006M 9 998M 9 841M 9 846M 9 829M 9 808M 9 549M 9 609M 9 447M 9 577M
otherAssets 0 0 0 0 0 0 1 0 0 0 0 0 0
totalAssets 20 744M 18 864M 19 687M 18 715M 18 458M 19 164M 20 433M 18 957M 19 194M 20 171M 21 073M 18 825M 17 576M
accountPayables 3 641M 2 718M 2 707M 2 697M 2 697M 2 768M 4 331M 2 931M 3 146M 3 044M 4 605M 3 063M 2 616M
shortTermDebt 1 949M 1 314M 2 040M 644M 495M 570M 429M 617M 743M 1 231M 1 063M 952M 1 836M
taxPayables 0 0 0 0 0 0 0 0 0 0 0 0 0
deferredRevenue 294M 234M 355M 0 726M 1 767M 711M 597M 0 0 0 1 067M 653M
otherCurrentLiabilities 1 084M 1 017M 1 258M 2 059M 1 292M 802M 1 495M 1 755M 2 732M 3 187M 2 820M 1 870M 1 221M
totalCurrentLiabilities 6 968M 5 282M 6 360M 5 401M 5 209M 5 907M 6 966M 5 899M 6 621M 7 462M 8 488M 6 952M 6 326M
longTermDebt 1 740M 1 701M 1 826M 1 824M 1 669M 1 671M 1 818M 1 777M 1 815M 1 817M 1 668M 1 631M 1 379M
deferredRevenueNonCurrent 0 0 0 0 0 0 0 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 0 0 0 0 0 0 0 0 0 0 0 0 0
otherNonCurrentLiabilities 828M 585M 712M 728M 665M 818M 951M 524M 0 0 0 549M 452M
totalNonCurrentLiabilities 2 568M 2 501M 2 538M 2 552M 2 334M 2 489M 2 769M 2 606M 1 815M 1 817M 1 668M 2 412M 2 233M
otherLiabilities 0 0 0 -728M 0 0 1 0 0 0 0 0 0
capitalLeaseObligations 50M 215M 0 0 0 50M 48M 304M 0 0 0 231M 401M
totalLiabilities 9 537M 7 784M 8 898M 7 225M 7 544M 8 397M 9 735M 8 505M 8 436M 9 279M 10 156M 9 364M 8 559M
preferredStock 2 264M 2 264M 2 264M 2 264M 2 264M 2 264M 2 264M 2 264M 2 264M 2 264M 2 264M 2 264M 2 264M
commonStock 0 0 0 3 781M 3 814M 3 860M 3 889M 3 979M 0 0 0 3 615M 3 612M
retainedEarnings 0 0 0 0 -3 814M -15 713M -3 889M -15 483M 0 0 2 672M 1 847M -6 745M
accumulatedOtherComprehensiveIncomeLoss 8 939M 8 813M 8 521M -297M 4 830M 8 498M 8 427M 8 184M -260M -257M -269M 7 192M 6 745M
othertotalStockholdersEquity 0 0 3 814M 11 853M 1 8 755M 8 885M -2 264M
totalStockholdersEquity 11 203M 11 077M 10 785M 11 490M 10 909M 10 762M 10 691M 10 448M 10 759M 10 892M 2 403M 9 456M 9 009M
totalEquity 11 207M 11 080M 10 788M 11 497M 10 914M 10 768M 10 697M 10 452M 10 764M 10 897M 2 403M 9 461M 9 017M
totalLiabilitiesAndStockholdersEquity 20 744M 19 687M 18 458M 19 164M 20 433M 19 194M 20 171M 21 073M
minorityInterest 3M 3M 3M 7M 6M 6M 6M 5M 5M 5M 6M 6M 8M
totalLiabilitiesAndTotalEquity 20 744M 18 864M 19 687M 18 715M 18 458M 19 164M 20 433M 18 957M 19 194M 20 171M 21 073M 18 825M 17 576M
totalInvestments 4 099M 3 994M 3 981M 4 379M 3 894M 3 900M 3 929M 3 907M 3 906M 3 791M 3 891M 3 783M 3 669M
totalDebt 3 689M 3 230M 3 866M 2 468M 2 164M 2 241M 2 247M 2 699M 2 558M 3 047M 2 731M 2 814M 3 616M
netDebt 3 232M 2 830M 3 462M 1 673M 1 854M 1 532M 828M 854M 1 561M 2 585M 2 095M 1 911M 3 074M
link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link
filingDate 2025-11-05 2024-11-06 2023-11-08 2022-11-02 2021-11-04
fiscalYear 2025 2024 2023 2022 2021
accountsReceivables 3 094M 3 550M 3 106M 3 548M 2 861M
otherReceivables 592M 0 0 0 0
prepaids 205M 202M 150M 0 0
totalPayables 2 718M 2 697M 2 931M 3 063M 2 616M
otherPayables 0 0 0 0 0
accruedExpenses 0 0 0 0 0
capitalLeaseObligationsCurrent 0 0 0 0 0
capitalLeaseObligationsNonCurrent 215M 0 304M 231M 401M
treasuryStock 0 0 0 0 0
additionalPaidInCapital 0 0 0 0 0
otherTotalStockholdersEquity 0 9 523M 11 504M -5 462M 3 132M

Cash Flow Statement

Property 2025 q4 2025 q3 2025 q2 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q3
date 2025-11-30 2025-08-31 2025-05-31 2024-08-31 2024-05-31 2024-02-29 2023-11-30 2023-08-31 2023-07-29 2023-04-29 2022-11-30 2022-08-31 2021-08-31
symbol CHSCP CHSCP CHSCP CHSCP CHSCP CHSCP CHSCP CHSCP CHSCP CHSCP CHSCP CHSCP CHSCP
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 823 277 823 277 823 277 823 277 823 277 823 277 823 277 823 277 897 429 897 429 823 277 823 277 823 277
fillingDate 2026-01-07 2025-07-09 2024-07-10 2024-04-03 2024-01-10 2023-08-30 2023-06-07 2023-01-11
acceptedDate 2026-01-07 11:00:59 2025-11-05 11:32:24 2025-07-09 11:50:59 2024-11-06 12:00:49 2024-07-10 11:30:51 2024-04-03 11:01:00 2024-01-10 12:45:33 2023-11-08 16:06:08 2023-08-30 16:29:47 2023-06-07 17:02:49 2023-01-11 13:00:49 2022-11-02 11:01:43 2021-11-04 08:01:15
calendarYear 2026 2025 2024 2024 2024 2023 2023 2023
period Q1 FY Q3 FY Q3 Q2 Q1 FY Q2 Q1 Q1 FY FY
netIncome 260M 598M 231M 1 102M 297M 170M 523M 1 900M 59M 40M 783M 1 679M 554M
depreciationAndAmortization 171M 651M 159M 482M 143M 140M 138M 465M 9M 10M 131M 462M 462M
deferredIncomeTax -11M -39M -12M -110M -35M 1M -69M -6M -16M 132 000 -2M 40M -12M
stockBasedCompensation 0 0 0 0 0 0 0 0 3M 3M 0 0 0
changeInWorkingCapital -669M -464M 433M -324M 78M -615M -752M 992M -70M -88M -961M -248M -190M
accountsReceivables -376M 7M -657M -336M -290M 265M -750M 646M 0 0 -779M -548M -569M
inventory -1 057M -53M 1 124M 148M 626M 320M -1 036M 438M -6M -17M -1 417M -318M -549M
accountsPayables 845M -276M 300M -214M 179M -1 493M 1 232M -127M 16M -19M 1 441M 555M 1 007M
otherWorkingCapital -81M -142M -334M 78M -258M 293M -198M 36M -79M -51M -206M 62M -80M
otherNonCashItems -89M -110M -116M 123M 38M 1 241M 842M -67M 45M 46M -131M 14M -55M
netCashProvidedByOperatingActivities -338M 636M 697M 1 273M 557M -250M -148M 3 284M 31M 12M -180M 1 947M 758M
investmentsInPropertyPlantAndEquipment 0 0 0 0 -199M -206M -151M -782M -11M -8M -123M -379M -359M
acquisitionsNet 0 -237M -927 000 16M 5M 5M 2M 30M 0 0 0 87M 102M
purchasesOfInvestments -157M 0 0 -500M 0 0 0 0 -4M -271 000 0 0 0
salesMaturitiesOfInvestments 135 000 513M 0 0 0 0 0 0 6M 2M 0 0 0
otherInvestingActivites -91M -505M -135M 115M 49M 0 0 12M
netCashUsedForInvestingActivites -248M -506M -334M -86M -100M -10M -6M -111M
debtRepayment 700M 58M 0 -9M -132M 0 -25M -1 887M
commonStockIssued 0 0 0 0 0 98 000 120 000 0
commonStockRepurchased 0 -288M -255M -356M -326M -5M -11M -496M 0 -20M 0 -112M -79M
dividendsPaid -42M -113M -107M -42M -42M 0 0 -42M
otherFinancingActivites -14M 3M -438M -324M -807 000 -183 000 -6M 2 060M
netCashUsedProvidedByFinancingActivities 644M -307M -546M -375M -175M -85 000 -51M 130M
effectOfForexChangesOnCash -260 000 773 000 -6M 2M 3M 1M -4M 3M 0 0 1M -15M -4M
netChangeInCash 58M -475M -124M -971M -319M -710M -426M 941M 21M -46M -160M 361M 325M
cashAtEndOfPeriod 458M 399M 404M 874M 390M 709M 1 419M 1 845M 129M 108M 744M 903M 542M
cashAtBeginningOfPeriod 399M 874M 528M 1 845M 709M 1 419M 1 845M 903M 108M 153M 903M 542M 217M
operatingCashFlow -338M 636M 697M 1 273M 557M -250M -148M 3 284M 31M 12M -180M 1 947M 758M
capitalExpenditure -120M -1 000M 0 -832M -199M -206M -151M -782M -11M -8M -123M -379M -359M
freeCashFlow -458M -364M 697M 441M 357M -456M -298M 2 502M 20M 4M -303M 1 567M 399M
link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link
filingDate 2025-11-05 2024-11-06 2023-11-08 2022-11-02 2021-11-04
fiscalYear 2025 2024 2023 2022 2021
otherInvestingActivities -1 157M -947M -198M -165M 155M
netCashProvidedByInvestingActivities -881M -1 432M -950M -457M -102M
netDebtIssuance 526M 74M -202M -785M -42M
longTermNetDebtIssuance 526M 74M -202M -785M -42M
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance -288M -356M -496M -112M -79M
netCommonStockIssuance -288M -356M -496M -112M -79M
commonStockIssuance 0 0 0 112M 79M
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid -469M -169M -169M -169M -169M
commonDividendsPaid 0 -169M -169M -169M -169M
preferredDividendsPaid -469M 0 0 0 0
otherFinancingActivities 600 000 -364M -529M -48M -37M
netCashProvidedByFinancingActivities -231M -814M -1 395M -1 114M -327M
incomeTaxesPaid 0 0 0 0 0
interestPaid 0 0 0 0 0

Earning call transcript

SEC forms

Show financial reports only

SEC form 8
2026-01-07 16:15 ET
CHS published news for 2025 q4
SEC form 8
2026-01-07 16:15 ET
CHS published news for 2025 q4
SEC form 10
2026-01-07 16:00 ET
CHS reported for 2025 q4
SEC form 8
2025-12-05 09:00 ET
CHS published news for 2025 q3
SEC form 8
2025-12-05 09:00 ET
CHS published news for 2025 q3
SEC form 8
2025-12-05 09:00 ET
CHS published news for 2025 q3
SEC form 8
2025-11-05 16:45 ET
CHS published news for 2025 q3
SEC form 8
2025-11-05 16:45 ET
CHS reported for 2025 q3
SEC form 10
2025-11-05 16:32 ET
CHS reported for 2025 q3
SEC form 8
2025-07-18 13:00 ET
CHS published news for 2025 q2
SEC form 8
2025-07-18 13:00 ET
CHS published news for 2025 q2
SEC form 8
2025-07-09 16:00 ET
CHS published news for 2025 q2
SEC form 8
2025-07-09 16:00 ET
CHS published news for 2025 q2
SEC form 10
2025-07-09 15:50 ET
CHS reported for 2025 q2
SEC form 10
2025-07-09 00:00 ET
CHS reported for 2025 q2
SEC form 10
2025-04-02 15:56 ET
CHS reported for 2025 q1
SEC form 10
2025-04-02 00:00 ET
CHS reported for 2025 q1
SEC form 8
2025-04-02 00:00 ET
CHS published news for 2025 q1
SEC form 8
2025-04-02 00:00 ET
CHS published news for 2025 q1
SEC form 10
2025-01-08 00:00 ET
CHS reported for 2024 q4
SEC form 8
2025-01-08 00:00 ET
CHS published news for 2024 q4
SEC form 8
2025-01-08 00:00 ET
CHS published news for 2024 q4
SEC form 8
2024-11-06 12:15 ET
CHS published news for 2024 q3
SEC form 8
2024-11-06 12:15 ET
CHS reported for 2024 q3
SEC form 10
2024-11-06 12:00 ET
CHS reported for 2024 q3
SEC form 10
2024-07-10 00:00 ET
CHS reported for 2024 q2
SEC form 8
2024-07-10 00:00 ET
CHS published news for 2024 q2
SEC form 8
2024-07-10 00:00 ET
CHS published news for 2024 q2
SEC form 8
2024-04-03 11:15 ET
CHS published news for 2024 q1
SEC form 8
2024-04-03 11:15 ET
CHS published news for 2024 q1
SEC form 10
2024-04-03 11:01 ET
CHS reported for 2024 q1
SEC form 10
2024-04-03 00:00 ET
CHS reported for 2024 q1
SEC form 10
2024-01-10 12:45 ET
CHS reported for 2023 q4
SEC form 10
2024-01-10 00:00 ET
CHS reported for 2023 q4
SEC form 8
2024-01-10 00:00 ET
CHS published news for 2023 q4
SEC form 8
2024-01-10 00:00 ET
CHS published news for 2023 q4
SEC form 10
2023-11-08 00:00 ET
CHS reported for 2023 q3
SEC form 8
2023-11-08 00:00 ET
CHS published news for 2023 q3
SEC form 10
2023-07-13 00:00 ET
CHS reported for 2023 q2
SEC form 8
2023-07-13 00:00 ET
CHS published news for 2023 q2
SEC form 6
2023-06-06 14:43 ET
CHS published news for 2023 q1
SEC form 6
2023-04-05 11:15 ET
CHS published news for 2023 q1
SEC form 10
2023-04-05 10:58 ET
CHS reported for 2023 q1
SEC form 10
2023-04-05 00:00 ET
CHS reported for 2023 q1
SEC form 8
2023-04-05 00:00 ET
CHS published news for 2023 q1
SEC form 6
2023-03-02 08:30 ET
CHS published news for 2022 q4
SEC form 6
2023-01-24 18:16 ET
CHS published news for 2022 q4
SEC form 6
2023-01-11 13:15 ET
CHS published news for 2022 q4
SEC form 10
2023-01-11 13:00 ET
CHS reported for 2022 q4
SEC form 10
2023-01-11 00:00 ET
CHS reported for 2022 q4
SEC form 8
2023-01-11 00:00 ET
CHS published news for 2022 q4
SEC form 6
2023-01-10 16:40 ET
CHS published news for 2022 q4
SEC form 6
2022-12-06 10:30 ET
CHS published news for 2022 q3
SEC form 6
2022-12-02 08:30 ET
CHS published news for 2022 q3
SEC form 6
2022-11-02 11:29 ET
CHS published news for 2022 q3
SEC form 10
2022-11-02 11:01 ET
CHS reported for 2022 q3
SEC form 10
2022-11-02 00:00 ET
CHS reported for 2022 q3
SEC form 8
2022-11-02 00:00 ET
CHS published news for 2022 q3
SEC form 6
2022-11-01 15:11 ET
CHS published news for 2022 q3
SEC form 6
2022-09-14 08:30 ET
CHS published news for 2022 q2
SEC form 6
2022-09-07 15:43 ET
CHS published news for 2022 q2
SEC form 6
2022-08-30 14:35 ET
CHS published news for 2022 q2
SEC form 6
2022-07-19 08:30 ET
CHS published news for 2022 q2
SEC form 6
2022-07-07 11:15 ET
CHS published news for 2022 q2
SEC form 10
2022-07-07 11:01 ET
CHS published news for 2022 q2
SEC form 10
2022-07-07 00:00 ET
CHS reported for 2022 q2
SEC form 8
2022-07-07 00:00 ET
CHS published news for 2022 q2
SEC form 6
2022-06-07 10:37 ET
CHS published news for 2022 q1
SEC form 6
2022-04-06 15:18 ET
CHS published news for 2022 q1
SEC form 6
2022-04-06 11:40 ET
CHS published news for 2022 q1
SEC form 10
2022-04-06 11:31 ET
CHS published news for 2022 q1
SEC form 10
2022-04-06 00:00 ET
CHS reported for 2022 q1
SEC form 8
2022-04-06 00:00 ET
CHS published news for 2022 q1
SEC form 6
2022-03-03 14:01 ET
CHS published news for 2021 q4
SEC form 6
2022-01-05 11:35 ET
CHS published news for 2021 q4
SEC form 10
2022-01-05 11:31 ET
CHS published news for 2021 q4
SEC form 10
2022-01-05 00:00 ET
CHS published news for 2021 q4
SEC form 8
2022-01-05 00:00 ET
CHS published news for 2021 q4
SEC form 6
2022-01-04 15:42 ET
CHS published news for 2021 q4
SEC form 6
2021-12-07 15:00 ET
CHS published news for 2021 q3
SEC form 6
2021-12-03 15:59 ET
CHS published news for 2021 q3
SEC form 6
2021-12-03 08:21 ET
CHS published news for 2021 q3
SEC form 6
2021-11-04 08:06 ET
CHS published news for 2021 q3
SEC form 10
2021-11-04 08:01 ET
CHS published news for 2021 q3
SEC form 10
2021-11-04 00:00 ET
CHS published news for 2021 q3
SEC form 8
2021-11-04 00:00 ET
CHS published news for 2021 q3
SEC form 6
2021-11-02 17:06 ET
CHS published news for 2021 q3
SEC form 6
2021-09-15 17:01 ET
CHS published news for 2021 q2
SEC form 6
2021-09-08 16:35 ET
CHS published news for 2021 q2
SEC form 6
2021-09-02 15:31 ET
CHS published news for 2021 q2
SEC form 6
2021-07-12 08:01 ET
CHS published news for 2021 q2
SEC form 6
2021-07-08 13:12 ET
CHS published news for 2021 q2
SEC form 10
2021-07-08 12:01 ET
CHS published news for 2021 q2
SEC form 10
2021-07-08 00:00 ET
CHS published news for 2021 q2
SEC form 8
2021-07-08 00:00 ET
CHS published news for 2021 q2
SEC form 6
2021-06-02 08:29 ET
CHS published news for 2021 q1
SEC form 10
2021-04-07 06:04 ET
CHS published news for 2021 q1
SEC form 6
2021-03-01 15:38 ET
CHS published news for 2020 q4
SEC form 6
2021-02-24 09:03 ET
CHS published news for 2020 q4
SEC form 10
2021-01-06 16:10 ET
CHS published news for 2020 q4
SEC form 6
2021-01-06 09:44 ET
CHS published news for 2020 q4
SEC form 6
2020-12-08 16:30 ET
CHS published news for 2020 q3
SEC form 6
2020-12-03 11:01 ET
CHS published news for 2020 q3
SEC form 10
2020-11-05 15:16 ET
CHS published news for 2020 q3
SEC form 6
2020-11-05 09:32 ET
CHS published news for 2020 q3